Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rossetti, L.
Right arrow Articles by Giaccari, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rossetti, L.
Right arrow Articles by Giaccari, A.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 40, Issue 4 444-448, Copyright © 1991 by American Diabetes Association


ARTICLES

Metabolic effects of IGF-I in diabetic rats

L Rossetti, S Frontoni, R Dimarchi, RA DeFronzo and A Giaccari
Department of Medicine, University of Texas Health Science Center, San Antonio 78284-7886.

Insulinlike growth factor I (IGF-I) stimulates glucose utilization (GU) in nondiabetic rats. We compared the effects of IGF-I and insulin on glucose metabolism in control (fed plasma glucose 7.7 +/- 0.1 mM, n = 30) and partially (90%) pancreatectomized diabetic (plasma glucose 18.4 +/- 0.8 mM, n = 30) awake unstressed rats. IGF-I was infused at 0.65 or 1.96 nmol.kg-1.min-1 and insulin at 22 or 29 pmol.kg-1.min-1 in combination with [3-3H]glucose while euglycemia was maintained by a variable glucose infusion. In controls, GU during the 0.65- and 1.96-nmol.kg-1.min-1 IGF-I infusions (127 +/- 7 and 168 +/- 4 mumol.kg-1.min-1, respectively) was similar to rates observed during the 22- and 29-pmol.kg-1.min-1 insulin infusions (121 +/- 2 and 156 +/- 5 mumol.kg-1.min-1). Whole-body glycolytic rate (3H2O generation) and muscle glycogen synthetic rate were identical during insulin and IGF-I infusions. In diabetic rats, GU was reduced by 30% versus control rats (P less than 0.01) during both the low-dose (88 +/- 7 vs. 121 +/- 7 mumol.kg-1.min-1) and higher-dose (109 +/- 4 vs. 156 +/- 5 mumol.kg-1.min-1) insulin clamps. The defect in insulin action involved both muscle glycogen synthesis and glycolysis. In diabetic rats, IGF-I elicited rates of GU similar to controls (115 +/- 10 and 164 +/- 12 mumol.kg-1.min-1 during the 0.65- and 1.96-nmol.kg-1.min-1 infusions, respectively) and corrected the intracellular defects in glycogen synthesis and glycolysis.(ABSTRACT TRUNCATED AT 250 WORDS)
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
Y. Ning, A. G. P. Schuller, S. Bradshaw, P. Rotwein, T. Ludwig, J. Frystyk, and J. E. Pintar
Diminished Growth and Enhanced Glucose Metabolism in Triple Knockout Mice Containing Mutations of Insulin-Like Growth Factor Binding Protein-3, -4, and -5
Mol. Endocrinol., September 1, 2006; 20(9): 2173 - 2186.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
T. Saukkonen, R. Amin, R. M. Williams, C. Fox, K. C. Yuen, M. A. White, A. M. Umpleby, C. L. Acerini, and D. B. Dunger
Dose-Dependent Effects of Recombinant Human Insulin-Like Growth Factor (IGF)-I/IGF Binding Protein-3 Complex on Overnight Growth Hormone Secretion and Insulin Sensitivity in Type 1 Diabetes
J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4634 - 4641.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
T. O'Connell and D. R. Clemmons
IGF-I/IGF-Binding Protein-3 Combination Improves Insulin Resistance By GH-Dependent and Independent Mechanisms
J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4356 - 4360.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
T. Pratipanawatr, W. Pratipanawatr, C. Rosen, R. Berria, M. Bajaj, K. Cusi, L. Mandarino, S. Kashyap, R. Belfort, and R. A. DeFronzo
Effect of IGF-I on FFA and glucose metabolism in control and type 2 diabetic subjects
Am J Physiol Endocrinol Metab, June 1, 2002; 282(6): E1360 - E1368.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. J. Fedele, C. H. Lang, and P. A. Farrell
Immunization against IGF-I prevents increases in protein synthesis in diabetic rats after resistance exercise
Am J Physiol Endocrinol Metab, June 1, 2001; 280(6): E877 - E885.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. J. Fedele, T. C. Vary, and P. A Farrell
Plasticity in Skeletal, Cardiac, and Smooth Muscle: Selected Contribution: IGF-I antibody prevents increases in protein synthesis in epitrochlearis muscles from refed, diabetic rats
J Appl Physiol, March 1, 2001; 90(3): 1166 - 1173.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L. J. Dominguez, M. Barbagallo, J. R. Sowers, and L. M. Resnick
Magnesium Responsiveness to Insulin and Insulin-Like Growth Factor I in Erythrocytes from Normotensive and Hypertensive Subjects
J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4402 - 4407.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
K. F. Petersen, R. Jacob, A. B. West, R. S. Sherwin, and G. I. Shulman
Effects of insulin-like growth factor I on glucose metabolism in rats with liver cirrhosis
Am J Physiol Endocrinol Metab, December 1, 1997; 273(6): E1189 - E1193.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. Y. Hokama, R. S. Streeper, and E. J. Henriksen
Voluntary exercise training enhances glucose transport in muscle stimulated by insulin-like growth factor I
J Appl Physiol, February 1, 1997; 82(2): 508 - 512.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Rossetti, N. Barzilai, W. Chen, T. Harris, D. Yang, and C. E. Rogler
Hepatic Overexpression of Insulin-like Growth Factor-II in Adulthood Increases Basal and Insulin-stimulated Glucose Disposal in Conscious Mice
J. Biol. Chem., January 5, 1996; 271(1): 203 - 208.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1991 by the American Diabetes Association.